Breast Cancer Clinical Trial
Preventing Lymphedema in Axillary Lymph Node Dissection
The researchers are trying to answer if axillary reverse mapping (ARM) with lympho-venous bypass (LVB) in patients undergoing an axillary lymph node dissection reduces the rate and severity of post-operative lymphedema of the arm.
All subjects will undergo an axillary lymph node dissection (ALND). Cluster randomization will determine which of these subjects will have the ARM with LVB and which subjects will have the ALND without this technique. As a baseline, all subjects will have the circumference of their arms measured and complete a questionnaire about lymphedema. Performing the measurements and answering a questionnaire will be repeated at 6, 12, 24, and 36 months after surgery.
Patients scheduled to undergo an axillary lymph node dissection
Patients who in the surgeon's judgement are at high risk to convert to an axillary lymph node dissection based intraoperative findings
Prior ipsilateral axillary lymph node dissection
Prior ipsilateral axillary radiation
Patients undergoing sentinel lymph node biopsy only or at low risk of converting to an axillary lymph node dissection in the surgeon's judgement
Previous treatment for lymphedema of either arm or prescribed prophylactic treatment for lymphedema.
Pregnant patients cannot participate in the substudy
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 2 Locations for this study
Jacksonville Florida, 32224, United States
Rochester Minnesota, 55905, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.